Research, Cytos Biotechnology AG, Wagistrasse 25, 8952 Schlieren-Zürich, Switzerland.
Nat Rev Immunol. 2010 Nov;10(11):787-96. doi: 10.1038/nri2868. Epub 2010 Oct 15.
Researchers working on the development of vaccines face an inherent dilemma: to maximize immunogenicity without compromising safety and tolerability. Early vaccines often induced long-lived protective immune responses, but tolerability was a major problem. Newer vaccines have very few side effects but can be of limited immunogenicity. One way to tackle this problem is to design vaccines that have all the properties of pathogens with the exception of causing disease. Key features of pathogens that can be mimicked by vaccine delivery systems are their size, shape and surface molecule organization. In addition, pathogen-associated molecular patterns can be used to induce innate immune responses that promote adaptive immunity. In this Review, we discuss the approaches currently being used to optimize the delivery of antigens and enhance vaccine efficacy.
既要最大限度地提高免疫原性,又要不影响安全性和耐受性。早期疫苗往往能诱导出长期的保护性免疫反应,但耐受性是一个主要问题。新型疫苗的副作用很少,但免疫原性可能有限。解决这个问题的一种方法是设计出除了引起疾病之外具有病原体所有特性的疫苗。疫苗输送系统可以模拟的病原体的关键特征是其大小、形状和表面分子组织。此外,病原体相关的分子模式可以用来诱导促进适应性免疫的先天免疫反应。在这篇综述中,我们讨论了目前用于优化抗原传递和增强疫苗效力的方法。